EPISODE · Jul 24, 2026 · 26 MIN
LUMVOA: New Breakthrough FDA-Approved Biologic Drug Treatment for Thyroid Eye Disease (TED)
from DoctorPodcasts || Cykiert Files · host Robert Cykiert, M.D. - Physician creator, writer, producer, director and host.
🎬Welcome to Episode 157 of the DoctorPodcasts Show! In this episode, host Dr. Robert Cykiert interviews board-certified ophthalmologist and oculoplastic surgeon Dr. Amy Patel Jain, M.D. to discuss a condition affecting thousands of people every day: Thyroid Eye Disease (TED). As a co-investigator in pivotal clinical trials, Dr. Patel Jain shares her deep expertise on how TED impacts patients' eyes and quality of life. We dive into traditional surgical treatments like orbital decompression, the paradigm shift brought on by #Tepezza, and breaking news regarding the June 2026 FDA approval of a brand-new five-infusion targeted biologic treatment: #Lumvoa.If you or a loved one are navigating the challenges of this autoimmune condition, this deep-dive interview offers the clinical insights and treatment options you need to know.Don't forget to SUBSCRIBE, FOLLOW, LIKE, and REPOST to help us spread awareness!⏳ Video Timeline (Chapters)0:00 — Introduction to Episode 157 & Guest Dr. Amy Patel Jain2:02 — What is Thyroid Eye Disease (TED) and How Does it Affect the Eyes?3:26 — TED vs. Graves' Disease: Can You Have TED Without an Active Thyroid Problem?4:21 — What Causes TED? The Role of TSH and IGF-1R Receptors5:08 — Who is at Risk? Demographics, Genetics, and the Impact of Smoking7:10 — How Many People in the USA Are Affected by TED?7:24 — Types of TED: Acute vs. Chronic and Active vs. Inactive Inflammation10:05 — How TED Affects Patient Quality of Life, Mental Health, and Daily Functioning11:19 — Traditional TED Treatments: Steroids, Radiation, and Multi-Stage Surgery13:25 — How Orbital Decompression Surgery Works (The "Ice Cream Cone" Analogy)15:25 — The Impact of Tepezza: A Paradigm Shift in Medical Treatment16:24 — Breaking News: How the New Drug Lumvoa Works (Mechanism of Action)17:33 — Lumvoa vs. Tepezza: Comparing Infusion Times, Frequency, and Treatment Burden18:35 — Clinical Results: How Quickly Do Patients See Results with Lumvoa?19:13 — Why TED Causes Diplopia (Double Vision) & Asymmetric Muscle Expansion20:39 — Main Side Effects and Clinical Considerations (Hypoglycemia, Hearing Changes, IBD)22:19 — Who is the Ideal Candidate for Lumvoa & Navigating the Viridian Cares Program24:18 — Will Biologics Reduce the Need for Severe Orbital Decompression Surgeries?25:42 — Outro & Closing Remarks🏷️ #ThyroidEyeDisease #TED #Lumvoa #Tepezza #GravesDisease #BulgingEyes #Ophthalmology #AutoimmuneDisease #DoubleVision #ThyroidAwareness #DoctorPodcastsShow #proptosis #exophthalmos Medical Disclaimer: This video is for informational and educational purposes only and does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Embed this episode
Ready to play
LUMVOA: New Breakthrough FDA-Approved Biologic Drug Treatment for Thyroid Eye Disease (TED)
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.